News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,245 Results
Type
Article (86995)
Company Profile (704)
Press Release (766544)
Multimedia
Podcasts (152)
Webinars (20)
Section
Business (232875)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91136)
Employer Resources (199)
FDA (18210)
Job Trends (17372)
News (396963)
Policy (39842)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56978)
ALS (123)
Alzheimer's disease (1614)
Antibody-drug conjugate (ADC) (192)
Approvals (18163)
Artificial intelligence (409)
Autoimmune disease (39)
Automation (21)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (42)
Breast cancer (408)
Cancer (3211)
Cardiovascular disease (258)
Career advice (3542)
Career pathing (34)
CAR-T (215)
CDC (43)
Cell therapy (592)
Cervical cancer (25)
Clinical research (74497)
Collaboration (1155)
Company closure (3)
Compensation (744)
Complete response letters (40)
COVID-19 (2916)
CRISPR (70)
C-suite (391)
Cystic fibrosis (125)
Data (3264)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (385)
Diagnostics (6995)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (193)
Drug pricing (156)
Drug shortages (36)
Duchenne muscular dystrophy (161)
Earnings (97841)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131635)
Executive appointments (927)
FDA (20091)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (42)
Gene therapy (463)
GLP-1 (947)
Government (5289)
Grass and pollen (7)
Guidances (222)
Healthcare (20921)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (15)
Indications (42)
Infectious disease (3121)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (130)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (602)
Leadership (27)
Legal (10139)
Liver cancer (85)
Longevity (12)
Lung cancer (449)
Lymphoma (226)
Machine learning (13)
Management (65)
Manufacturing (479)
MASH (104)
Medical device (14751)
Medtech (14758)
Mergers & acquisitions (22615)
Metabolic disorders (980)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2410)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (498)
Opinion (293)
Ovarian cancer (108)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (204)
Partnered (25)
Patents (340)
Patient recruitment (188)
Peanut (55)
People (65800)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22979)
Phase II (32346)
Phase III (24365)
Pipeline (1791)
Policy (254)
Postmarket research (3554)
Preclinical (10380)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (545)
Real estate (7402)
Recruiting (76)
Regulatory (27325)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (105)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (941)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (64)
Last 7 days (566)
Last 30 days (1946)
Last 365 days (33731)
2025 (19784)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50603)
Australia (8892)
California (8040)
Canada (2490)
China (745)
Colorado (342)
Connecticut (358)
Delaware (215)
Europe (116138)
Florida (1200)
Georgia (274)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1135)
Massachusetts (6151)
Michigan (280)
Minnesota (501)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2253)
New Mexico (31)
New York (2238)
North Carolina (1267)
North Dakota (10)
Northern California (3494)
Ohio (261)
Oklahoma (17)
Oregon (48)
Pennsylvania (1721)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2993)
Tennessee (132)
Texas (1245)
United States (30306)
Utah (234)
Virginia (221)
Washington D.C. (80)
Washington State (706)
West Virginia (4)
Wisconsin (87)
There are 854,245 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury
August 4, 2025
·
13 min read
Press Releases
Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-101
August 4, 2025
·
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
·
4 min read
Press Releases
Marea Therapeutics Enrolls First Patient in Phase 2b TYDAL-TIMI 78 Clinical Study Evaluating MAR001 in Adults at Risk of ASCVD
August 4, 2025
·
3 min read
Press Releases
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference
August 4, 2025
·
2 min read
Press Releases
BMI OrganBank Secures FDA Breakthrough Device Designation for Innovative Kidney Transplant Technology
August 4, 2025
·
2 min read
Press Releases
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
August 4, 2025
·
1 min read
Press Releases
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007
August 4, 2025
·
6 min read
Press Releases
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe
August 4, 2025
·
3 min read
Immuno-oncology
Top FDA Cancer Regulator Intervened To Reject Replimmune’s Melanoma Drug
According to reporting from multiple outlets, Richard Pazdur, head of the Oncology Center of Excellence at CDER, opposed the consensus opinion of CBER staff to approve the drug. Replimmune’s stock has dropped precipitously since the rejection.
August 4, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 85,425
Next
